i-Dialco
I think we have to look at more than just the deadline with Informed. Based on the press release it appears as though Dialco had specific performance targets that had to be met as well. It could be that it's better to retain 30% of a very viable company while at the same time relieving the burden of financing and sales targets while Dimi gets FDA approval. My guess is this is the best deal they could negotiate but in reality it's still a great assett for Spectral IMHO.